Source Legend
- Human-provided
Entered or confirmed by an authorized person.
- Google
Imported Google information.
- Trial-derived
Calculated or extracted directly from associated trial records.
- AI-inferred
A capability inferred from trial history.
- AI-extracted
An explicit statement extracted from an official source.
- Public registry
Information from a public registry.
- Site record
Information held in the site record.
Source: Site record. Velocity Clinical Research - Gulfport, Mississippi
Basic Information
Site Overview
Velocity's research site in Gulfport was founded in 2016 as the second site of MedPharmics and acquired by Velocity in 2022. Since its inception, the site has conducted trials in Infectious Diseases and Women’s Health, including over 25 vaccine trials. Our Gulfport site played an integral role during the height of the COVID-19 pandemic, completing COVID-19 trials for both children and adults. Located directly off Highway 49 in an independent medical office building on Dedeaux Road, the site is easily accessible with abundant parking. Additionally, the site is close to the local hospital. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Gulfport team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.
Affiliations
Associated Organizations
Conditions
Sponsors
Research Technology
Research technology inferred from trial participation
Imaging & Diagnostics
Imaging and diagnostic capabilities inferred from trial participation
Laboratory & Biospecimens
Laboratory and biospecimen capabilities inferred from trial participation
Clinical Procedures
Clinical procedures inferred from trial participation
Accessibility & Parking
Accessibility Features
Additional Capabilities
Other capabilities inferred from trial participation